Cart: 0 items inside
Bestsellers
Anti-allergic/Asthma
Antibiotics
Antidepressants
Antidiabetic
Antiviral
Anxiety/Sleep Aid
Blood Pressure/Heart
Cancer
Cholesterol
Eye Care
General Health
Men's Health
Mental Health/Epilepsy
Pain Relief
Pets
Skin Care
Stomach
Stop Smoking
Vitamins/Herbal Supplements
Weight Loss
Women's Health

Aggrenox

Aggrenox 25mg/200mg

60 pills
25mg/200mg
$64.80
$1.08
per item
120 pills
25mg/200mg
$109.20
$20.40
saving
$0.91
per item
180 pills
25mg/200mg
$129.60
$64.80
saving
$0.72
per item

Bonus Policy

  • 4 free bonus pills for all orders!
  • Free Regular Airmail (10-21 days) for orders starting with $150.00!
  • Free Express Courier (US Customers Only) (8-14 days) for orders starting with $300.00!
  • Free insurance (guaranteed reshipment if delivery failed) for orders starting with $200.00!

Description

Aggrenox (generic name: Dipyridamole / Aspirin; brand name: Asasantin Retard) is an effective combination of two anti-platelet medicines, aspirin and dipyridamole.

Each Aggrenox capsule contains 200 mg dipyridamole in an extended-release form and 25 mg aspirin, as an immediate-release sugar-coated tablet.

Platelets are very small blood cells which clump together during blood clotting. By preventing this clumping, anti-platelet medicines reduce the chances of blood clots forming (a process called thrombosis).

Aggrenox is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain (transient ischemic attack, TIA) or completed ischemic stroke due to thrombosis.

Aggrenox makes platelets in the blood less sticky so they do not clump together and form blood clots.

Aggrenox was proven effective in a large international stroke prevention trial - the Second European Stroke Prevention Study (ESPS 2). In the study, Aggrenox:

Prevented twice as many strokes as aspirin, the most widely used stroke prevention treatment
Reduced the risk of recurrent stroke in patients with heart disease and high blood pressure

As a result, Aggrenox is recommended as a first-line treatment option for reducing the risk of stroke after TIA/stroke by:

National Stroke Association
American Heart Association
American College of Chest Physicians


Full Aggrenox description »